Premium Research

Resource Trader Subscription Alert
Most traders are starting to price in another leg down.
Weiss Investor Signals Subscription Your Issue
A healthy dose of drug stocks has turned out to be a great investment prescription.
Strategic Options Subscription
In 2022, investors have contended with a messy war in Eastern Europe, worldwide inflation and supply chain bottlenecks. It’s been a tough slog, yet there are better times ahead. The world is...
Strategic Options Subscription Alert
Stocks are kicking off the week with losses and bond yields climbed as a U.S. services gauge rose unexpectedly.
Safe Money Report Subscription Your Issue
Today, I’m talking to Nilus Mattive, associate editor of Safe Money Report.
Safe Money Report Subscription Your Issue
This week, I have the pleasure of sitting down with Kenny Polcari, host of Wealth & Wisdom, who interviews those in the know.
Strategic Options Subscription
Bears started Friday with all guns blazing. The S&P 500 splattered to an early 1.2% loss on a crazy hot November payrolls report. That's when bulls sneaked into the battlefield and nearly...
While the stock market has many investors worried, here’s why the next major move will be upward.
Weekend Windfalls Subscription Alert
When Fed Chair Powell confirmed smaller hikes on Wednesday, your new covered call started to trigger.
Wealth Megatrends Subscription
A slew of issues tossed the market around this week, but your portfolio’s still doing great.
Top Tech Stocks
See All »
B
AAPL NASDAQ $348.73
B
MSFT NASDAQ $505.92
B
NVDA NASDAQ $148.79
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.27
B
Top Financial Stocks
See All »
A
B
JPM NYSE $320.27
B
V NYSE $402.86
Top Energy Stocks
See All »
B
CVX NYSE $206.41
B
COP NYSE $134.31
Top Health Care Stocks
See All »
B
LLY NYSE $1,354.81
B
JNJ NYSE $266.45
B
ABBV NYSE $283.03
Top Real Estate Stocks
See All »
B
PLD NYSE $123.24